Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
|
0.827 | 0.160 | 3 | 50331654 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.827 | 0.160 | 3 | 50331654 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2014 | ||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.827 | 0.160 | 3 | 50331654 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | < 0.001 | 1 | 2005 | 2005 | |||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.882 | 0.040 | 3 | 50334001 | intron variant | C/A | snv | 0.39 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.160 | 3 | 50342473 | missense variant | A/G | snv | 2.0E-04 | 3.5E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Otorhinolaryngologic Diseases; Cardiovascular Diseases | 0.700 | 0 | |||||||||
|
0.925 | 0.160 | 3 | 50342473 | missense variant | A/G | snv | 2.0E-04 | 3.5E-05 |
|
0.800 | 1.000 | 4 | 2013 | 2018 | |||||||
|
1.000 | 3 | 50342047 | stop gained | G/A | snv | 8.0E-06 | 7.0E-06 |
|
0.700 | 0 | |||||||||||
|
1.000 | 3 | 50341685 | missense variant | T/C | snv | 1.2E-05 |
|
0.700 | 0 | ||||||||||||
|
3 | 50342917 | splice donor variant | C/T | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 2 | 2013 | 2013 | |||||||||
|
0.925 | 0.160 | 3 | 50342473 | missense variant | A/G | snv | 2.0E-04 | 3.5E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Skin and Connective Tissue Diseases; Immune System Diseases; Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
1.000 | 0.040 | 3 | 50331640 | missense variant | C/T | snv | 1.4E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.827 | 0.160 | 3 | 50331654 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.763 | 0.280 | 3 | 50332115 | missense variant | C/A | snv | 9.6E-02 | 8.0E-02 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2006 | 2014 | ||||||
|
0.827 | 0.160 | 3 | 50331654 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.790 | 0.160 | 3 | 50341515 | intron variant | A/G | snv | 0.22 | 0.20 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
|
0.925 | 0.080 | 3 | 50331675 | missense variant | T/G | snv | 8.0E-06 | 1.4E-05 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.827 | 0.160 | 3 | 50331654 | missense variant | G/A | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 |